{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:42:55Z","timestamp":1790476975234,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine Reviews"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.smrv.2024.101997","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T17:43:52Z","timestamp":1725039832000},"page":"101997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Excessive daytime sleepiness in obstructive sleep apnea: Indirect treatment comparison of wake-promoting agents in patients adherent\/nonadherent to primary OSA therapy"],"prefix":"10.1016","volume":"78","author":[{"given":"Yuxin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5315-7771","authenticated-orcid":false,"given":"Yi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.smrv.2024.101997_bib1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40248-019-0186-3","article-title":"Long term management of obstructive sleep apnea and its comorbidities","volume":"14","author":"Marin-Oto","year":"2019","journal-title":"Multidiscip Respir Med"},{"key":"10.1016\/j.smrv.2024.101997_bib2","first-page":"1311","article-title":"Obstructive sleep apnea is a common disorder in the population-a review on the epidemiology of sleep apnea","volume":"7","author":"Franklin","year":"2015","journal-title":"J Thorac Dis"},{"issue":"8","key":"10.1016\/j.smrv.2024.101997_bib3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S2213-2600(19)30226-7","article-title":"The global burden of sleep apnoea","volume":"7","author":"Grote","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.smrv.2024.101997_bib4","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S2213-2600(19)30198-5","article-title":"Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis","volume":"7","author":"Benjafield","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.smrv.2024.101997_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11325-014-1015-8","article-title":"Occupational health of patients with obstructive sleep apnea syndrome: a systematic review","volume":"19","author":"Guglielmi","year":"2015","journal-title":"Sleep Breath"},{"key":"10.1016\/j.smrv.2024.101997_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.sleep.2007.01.009","article-title":"The impact of obstructive sleep apnea and daytime sleepiness on work limitation","volume":"9","author":"Mulgrew","year":"2007","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2024.101997_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5664\/jcsm.7624","article-title":"Comorbidities, health-related quality of life, and work productivity among people with obstructive sleep apnea with excessive sleepiness: findings from the 2016 US national health and wellness survey","volume":"15","author":"Stepnowsky","year":"2019","journal-title":"J Clin Sleep Med"},{"issue":"6","key":"10.1016\/j.smrv.2024.101997_bib8","doi-asserted-by":"crossref","first-page":"573","DOI":"10.5664\/jcsm.27662","article-title":"Obstructive sleep apnea and risk of motor vehicle crash: systematic review and meta-analysis","volume":"5","author":"Tregear","year":"2009","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.smrv.2024.101997_bib9","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2024.101997_bib10","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0013-4694(97)00010-2","article-title":"A normative study of the maintenance of wakefulness test (MWT)","volume":"103","author":"Doghramji","year":"1997","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.smrv.2024.101997_bib11","doi-asserted-by":"crossref","first-page":"471","DOI":"10.7326\/0003-4819-159-11-201312030-00009","article-title":"Management of obstructive sleep apnea in adults: a clinical practice guideline from the American College of Physicians","volume":"159","author":"Qaseem","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.smrv.2024.101997_bib12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.5664\/jcsm.7640","article-title":"Treatment of adult obstructive sleep apnea with positive airway pressure: an American academy of sleep medicine clinical practice guideline","volume":"15","author":"Patil","year":"2019","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.smrv.2024.101997_bib13","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1183\/09031936.00016808","article-title":"Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: the French multicentre study","volume":"33","author":"P\u00e9pin","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.smrv.2024.101997_bib14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/jsr.12039","article-title":"Residual sleepiness in sleep apnea patients treated by continuous positive airway pressure","volume":"22","author":"Gasa","year":"2013","journal-title":"J Sleep Res"},{"key":"10.1016\/j.smrv.2024.101997_bib15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.5664\/jcsm.7638","article-title":"Treatment of adult obstructive sleep apnea with positive airway pressure: an American academy of sleep medicine systematic review, meta-analysis, and GRADE assessment","volume":"15","author":"Patil","year":"2019","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.smrv.2024.101997_bib16","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/thx.2005.050583","article-title":"Continuous positive airway pressure reduces daytime sleepiness in mild to moderate obstructive sleep apnoea: a meta-analysis","volume":"61","author":"Marshall","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.smrv.2024.101997_bib17","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.5665\/sleep.4912","article-title":"Modafinil increases Awake EEG activation and improves performance in obstructive sleep apnea during continuous positive airway pressure withdrawal","volume":"38","author":"Wang","year":"2015","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2024.101997_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40463-016-0156-0","article-title":"Trends in CPAP adherence over twenty years of data collection: a flattened curve","volume":"45","author":"Rotenberg","year":"2016","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.smrv.2024.101997_bib19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.chest.2021.02.033","article-title":"Randomized controlled trial of solriamfetol for excessive daytime sleepiness in OSA: an analysis of subgroups adherent or nonadherent to OSA treatment","volume":"160","author":"Schweitzer","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.smrv.2024.101997_bib20","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/MCP.0000000000000724","article-title":"Endotypes and phenotypes in obstructive sleep apnea","volume":"26","author":"Malhotra","year":"2020","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.smrv.2024.101997_bib21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1183\/23120541.00126-2022","article-title":"Current and novel treatment options for obstructive sleep apnoea","volume":"8","author":"Randerath","year":"2022","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.smrv.2024.101997_bib22","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1513\/AnnalsATS.202006-696FR","article-title":"Excessive daytime sleepiness in obstructive sleep apnea. Mechanisms and clinical management","volume":"18","author":"Lal","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.smrv.2024.101997_bib23","unstructured":"NDA approval for nuvigil (armodafinil) in Obstructive sleep apnea\/hypopnea syndrome, narcolepsy, and shift work sleep disorder 2007. US Food Drug Adm n.d."},{"key":"10.1016\/j.smrv.2024.101997_bib24","unstructured":"NDA approval for sunosi (solriamfetol) in narcolepsy and obstructive sleep apnea 2019. US food drug adm n.d."},{"key":"10.1016\/j.smrv.2024.101997_bib25","unstructured":"Supplemental NDA approval for provigil (modafinil) tablets in obstructive sleep apnea\/hypopnea syndrome and shift work sleep disorder 2004. US food drug adm n.d."},{"key":"10.1016\/j.smrv.2024.101997_bib26","unstructured":"Aculys pharma initiates phase 3 trial of pitolisant treating patients with excessive daytime sleepiness associated with obstructive sleep apnea syndrome 2023 n.d."},{"key":"10.1016\/j.smrv.2024.101997_bib27","doi-asserted-by":"crossref","first-page":"676","DOI":"10.7326\/M22-3473","article-title":"Comparative efficacy and safety of wakefulness-promoting agents for excessive daytime sleepiness in patients with obstructive sleep apnea : a systematic review and network meta-analysis","volume":"176","author":"Pitre","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.smrv.2024.101997_bib28","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.5664\/jcsm.5096","article-title":"Effect of wakefulness-promoting agents on sleepiness in patients with sleep apnea treated with CPAP: a meta-analysis","volume":"11","author":"Sukhal","year":"2015","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.smrv.2024.101997_bib29","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.5664\/jcsm.9610","article-title":"Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea","volume":"17","author":"Ronnebaum","year":"2021","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.smrv.2024.101997_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.smrv.2024.101997_bib31","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.smrv.2024.101997_bib32","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1164\/rccm.201806-1100OC","article-title":"Solriamfetol for excessive sleepiness in obstructive sleep apnea (tones 3). A randomized controlled trial","volume":"199","author":"Schweitzer","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.smrv.2024.101997_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"key":"10.1016\/j.smrv.2024.101997_bib34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4088\/JCP.09m05536gry","article-title":"A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression","volume":"71","author":"Krystal","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.smrv.2024.101997_bib35","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.rmed.2006.06.007","article-title":"Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea\/hypopnea syndrome","volume":"101","author":"Hirshkowitz","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.smrv.2024.101997_bib36","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.clinthera.2006.05.013","article-title":"Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea\/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults","volume":"28","author":"Roth","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.smrv.2024.101997_bib37","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1389-9457(03)00108-4","article-title":"Effect of modafinil on sustained attention performance and quality of life in OSA patients with residual sleepiness while being treated with nCPAP","volume":"4","author":"Dinges","year":"2003","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2024.101997_bib38","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5664\/jcsm.2912","article-title":"Efficacy and safety of adjunctive modafinil treatment on residual excessive daytime sleepiness among nasal continuous positive airway pressure-treated Japanese patients with obstructive sleep apnea syndrome: a double-blind placebo-controlled study","volume":"9","author":"Inoue","year":"2013","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.smrv.2024.101997_bib39","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1164\/ajrccm.164.9.2103032","article-title":"Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea","volume":"164","author":"Pack","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.smrv.2024.101997_bib40","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/sleep\/28.4.464","article-title":"Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea\/hypopnea syndrome","volume":"28","author":"Black","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2024.101997_bib41","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1164\/rccm.201907-1284OC","article-title":"Pitolisant for daytime sleepiness in patients with obstructive sleep apnea who refuse continuous positive airway pressure treatment. A randomized trial","volume":"201","author":"Dauvilliers","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.smrv.2024.101997_bib42","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.chest.2020.09.281","article-title":"Pitolisant for residual excessive daytime sleepiness in OSA patients adhering to CPAP: a randomized trial","volume":"159","author":"P\u00e9pin","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.smrv.2024.101997_bib43","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.pnpbp.2007.10.016","article-title":"Placebo and modafinil effect on sleepiness in obstructive sleep apnea","volume":"32","author":"Bittencourt","year":"2008","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.smrv.2024.101997_bib44","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/thoraxjnl-2013-203796","article-title":"Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trial","volume":"69","author":"Chapman","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.smrv.2024.101997_bib45","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/ajrccm.163.4.2005036","article-title":"Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea\/hypopnea syndrome","volume":"163","author":"Kingshott","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.smrv.2024.101997_bib46","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.chest.2018.11.005","article-title":"Solriamfetol for the treatment of excessive sleepiness in OSA: a placebo-controlled randomized withdrawal study","volume":"155","author":"Strollo","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.smrv.2024.101997_bib47","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.sleep.2013.04.010","article-title":"Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study","volume":"14","author":"Herring","year":"2013","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2024.101997_bib48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5664\/jcsm.3440","article-title":"Effect of armodafinil on cortical activity and working memory in patients with residual excessive sleepiness associated with CPAP-treated OSA: a multicenter fMRI study","volume":"10","author":"Greve","year":"2014","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.smrv.2024.101997_bib49","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1513\/AnnalsATS.202002-136OC","article-title":"Effects of solriamfetol on quality-of-life measures from a 12-week phase 3 randomized controlled trial","volume":"17","author":"Weaver","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.smrv.2024.101997_bib50","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2147\/NSS.S245020","article-title":"Profile of solriamfetol in the management of excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea: focus on patient selection and perspectives","volume":"13","author":"Abad","year":"2021","journal-title":"Nat Sci Sleep"},{"key":"10.1016\/j.smrv.2024.101997_bib51","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.clinthera.2016.02.004","article-title":"Effects of modafinil and armodafinil in patients with obstructive sleep apnea: a meta-analysis of randomized controlled trials","volume":"38","author":"Kuan","year":"2016","journal-title":"Clin Ther"},{"key":"10.1016\/j.smrv.2024.101997_bib52","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1124\/jpet.118.248120","article-title":"Characterization of the neurochemical and behavioral effects of solriamfetol (JZP-110), a selective dopamine and norepinephrine reuptake inhibitor","volume":"366","author":"Baladi","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.smrv.2024.101997_bib53","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/bs.apha.2023.10.006","article-title":"Modafinil, an atypical CNS stimulant?","volume":"99","author":"Hersey","year":"2024","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.smrv.2024.101997_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.855","article-title":"Pitolisant, a wake-promoting agent devoid of psychostimulant properties: preclinical comparison with amphetamine, modafinil, and solriamfetol","volume":"9","author":"Krief","year":"2021","journal-title":"Pharmacol Res Perspect"}],"container-title":["Sleep Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087079224001011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087079224001011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T03:10:18Z","timestamp":1732417818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1087079224001011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":54,"alternative-id":["S1087079224001011"],"URL":"https:\/\/doi.org\/10.1016\/j.smrv.2024.101997","relation":{},"ISSN":["1087-0792"],"issn-type":[{"value":"1087-0792","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Excessive daytime sleepiness in obstructive sleep apnea: Indirect treatment comparison of wake-promoting agents in patients adherent\/nonadherent to primary OSA therapy","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smrv.2024.101997","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101997"}}